<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen CD</submitter><funding>NIA NIH HHS</funding><funding>National Institute on Aging</funding><pagination>7234-7246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7302970</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(6)</volume><pubmed_abstract>There is an unmet need for treatments for diseases associated with aging. The antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process. Thus, upregulating Klotho in the brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis. We attempted to upregulate Klotho for its beneficial effects in the brain and elsewhere. Here, we describe a method to specifically activate Klotho gene expressi</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone.</pubmed_title><pmcid>PMC7302970</pmcid><funding_grant_id>R44 AG053084</funding_grant_id><funding_grant_id>1R44 AG053084</funding_grant_id><pubmed_authors>Abraham CR</pubmed_authors><pubmed_authors>Zeldich E</pubmed_authors><pubmed_authors>Rudy MA</pubmed_authors><pubmed_authors>Chen CD</pubmed_authors></additional><is_claimable>false</is_claimable><name>A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone.</name><description>There is an unmet need for treatments for diseases associated with aging. The antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process. Thus, upregulating Klotho in the brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis. We attempted to upregulate Klotho for its beneficial effects in the brain and elsewhere. Here, we describe a method to specifically activate Klotho gene expressi</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-03T23:43:49.041Z</modification><creation>2022-02-10T12:48:43.321Z</creation></dates><accession>S-EPMC7302970</accession><cross_references><pubmed>32347987</pubmed><doi>10.1096/fj.202000171R</doi><doi>10.1096/fj.202000171r</doi></cross_references></HashMap>